Author details

Full Name

Pratiti Bandopadhayay

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37715730	Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.	Neuro Oncol	2024
38039965	A road map for the treatment of pediatric diffuse midline glioma.	Cancer Cell	2024
37944912	Pediatric low-grade glioma: State-of-the-art and ongoing challenges.	Neuro Oncol	2024
37498309	A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma.	Clin Cancer Res	2023
35977048	BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.	Neuro Oncol	2023
37609311	Noninvasive molecular subtyping of pediatric low-grade glioma with self-supervised transfer learning.	medRxiv	2023
37286821	Genome-wide pooled CRISPR screening in neurospheres.	Nat Protoc	2023
36780194	ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.	Clin Cancer Res	2023
37205492	Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma.	bioRxiv	2023
36566593	Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.	Neoplasia	2023
36697832	Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.	Nature	2023
36932243	Accurate diagnosis of pediatric brain cancers.	Nat Med	2023
37531270	LOGGIC of RNA-sequencing in enhancing diagnoses of pediatric low-grade gliomas.		2023
34477207	The challenges in treating embryonal tumors with multilayered rosettes (ETMR) and other infant brain tumors.	Neuro-Oncology	2022
35973991	Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma.	Nat Commun	2022
36226704	Molecular genetics of paediatric brain tumours and opportunities for precision medicine - a focus on infant tumours.	Current Opinion in Neurology	2022
36335782	Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.	Eur J Cancer	2022
35802025	FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.	Cancer Res	2022
35788723	Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.	Nat Cancer	2022
35664557	Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data.	Neurooncol Adv	2022
36471070	K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas.	Nat Genet	2022
36926246	Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment.	Neurooncol Adv	2022
34984433	Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.	Neuro Oncol	2022
34668975	Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.	Neuro Oncol	2022
35105861	PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.	Nat Commun	2022
34580728	Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.	Journal of Neuropathology and Experimental Neurology	2021
33753930	A first-generation pediatric cancer dependency map.	Nat Genet	2021
33565268	Outcomes after first relapse of childhood intracranial ependymoma.	Pediatric Blood and Cancer	2021
33601323	Bromodomain and extra-terminalÂ inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.	Eur J Cancer	2021
33278109	Advances in the classification and treatment of pediatric brain tumors.	Current Opinion in Pediatrics	2021
32780261	Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.	Journal of Neuro-Oncology	2020
32322066	Mechanisms and therapeutic implications of hypermutation in gliomas.	Nature	2020
31935369	Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.	Cancer Cell	2020
32289265	The "Risk" in Pediatric Low-Grade Glioma.	Cancer Cell	2020
33259802	Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.	Cell	2020
33234154	CloneSifter: enrichment of rare clones from heterogeneous cell populations.	BMC Biology	2020
31160565	Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.	Nat Commun	2019
31748746	Longitudinal molecular trajectories of diffuse glioma in adults.	Nature	2019
31794268	The Power of Human Cancer Genetics as Revealed by Low-Grade Gliomas.	Annu Rev Genet	2019
31571114	Increasing value of autopsies in patients with brain tumors in the molecular era.	J Neurooncol	2019
30535093	Old meet new-the path to combination treatments in pediatric low-grade gliomas.	Neuro-Oncology	2019
30531227	Management of pediatric low-grade glioma.	Current Opinion in Pediatrics	2019
31229353	Towards Immunotherapy for Pediatric Brain Tumors.	Trends in Immunology	2019
30860482	Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibition.	Elife	2019
31427603	Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells.	Nat Commun	2019
29542703	Landscapes of childhood tumours.	Nature	2018
29016845	Pediatric low-grade gliomas: next biologically driven steps.	Neuro Oncol	2018
30537514	Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.	Cancer Cell	2018
30089904	Genetic and transcriptional evolution alters cancer cell line drug response.	Nature	2018
29674595	Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.	Science	2018